| Date Checked | 2025-12-21 23:38:20 |
|---|---|
| Graham Number | (PB)44.77 vs (PE)45.21 |
| Over / Under Value Percentage | 89.32% vs 88.33% |
| Dividend Yield | 1.72% |
| Dividend Date | 2025-09-08 |
| Symbol | AZN |
| AssetType | Common Stock |
| Name | AstraZeneca PLC ADR |
| Description | AstraZeneca PLC is a leading global biopharmaceutical company based in Cambridge, UK, that focuses on the discovery, development, and commercialization of innovative prescription medicines across diverse therapeutic areas, including oncology, cardiovascular, renal, respiratory, and neuroscience. With a strong pipeline of candidates and an unwavering commitment to addressing unmet medical needs, AstraZeneca employs cutting-edge scientific research and strategic partnerships to advance its growth trajectory and enhance patient outcomes globally. The company is also dedicated to sustainability and is well-positioned to capitalize on the dynamic trends shaping the healthcare industry. |
| CIK | 901832 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | DRUG MANUFACTURERS - GENERAL |
| Address | 1 FRANCIS CRICK AVENUE, CAMBRIDGE, UNITED KINGDOM, CB2 0AA |
| OfficialSite | https://www.astrazeneca.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 281686508000 |
| EBITDA | 20416000000 |
| PERatio | 30.18 |
| PEGRatio | 1.041 |
| BookValue | 29.59 |
| DividendPerShare | 3.13 |
| EPS | 3.01 |
| RevenuePerShareTTM | 3.113 |
| ProfitMargin | 0.162 |
| OperatingMarginTTM | 0.241 |
| ReturnOnAssetsTTM | 0.0906 |
| ReturnOnEquityTTM | 0.217 |
| RevenueTTM | 58127000000 |
| GrossProfitTTM | 48395002000 |
| DilutedEPSTTM | 3.01 |
| QuarterlyEarningsGrowthYOY | 0.78 |
| QuarterlyRevenueGrowthYOY | 0.12 |
| AnalystTargetPrice | 96.86 |
| AnalystRatingStrongBuy | 2 |
| AnalystRatingBuy | 8 |
| AnalystRatingHold | 1 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | 30.18 |
| ForwardPE | 17.61 |
| PriceToSalesRatioTTM | 4.846 |
| PriceToBookRatio | 6.12 |
| EVToRevenue | 5.31 |
| EVToEBITDA | 17.18 |
| Beta | 0.169 |
| 52WeekHigh | 94.02 |
| 52WeekLow | 60.83 |
| 50DayMovingAverage | 84.75 |
| 200DayMovingAverage | 76.19 |
| SharesOutstanding | 3100567000 |
| SharesFloat | 1543307000 |
| PercentInsiders | 0.003 |
| PercentInstitutions | 16.726 |
| ExDividendDate | 2025-08-08 |
| naga | 0 |
| etoro | 1 |
| dateChecked | 2025-12-21 23:38:20 |
| fresh | 1 |